查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1517429

全球醫療應用生物聚合物市場規模研究，按類型、來源、應用和區域預測 2022-2032

Global Biopolymers for Medical Applications Market Size Study, by Type, by Source, by Application, and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 200 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年，全球醫療應用生物聚合物市場價值約為24.3億美元，預計在2024-2032年預測期內將以超過23.24%的健康成長率成長。生物聚合物是天然或生物合成的聚合物，對於製造尖端醫療工具和設備至關重要，例如可生物分解的支架、藥物傳輸系統和縫合線，因其與人體的相容性、自然分解和降低的毒性而受到讚賞。由於對生物相容性材料的需求激增和突破性的技術進步，它們的應用廣泛，涵蓋再生醫學、製藥和外科手術。市場充滿機遇，生產效率方面有望取得進步，以及具有刺激響應性等智慧功能特性的新型生物聚合物。然而，該產業面臨許多限制，包括高昂的研發成本、嚴格的監管環境以及來自合成聚合物的競爭。

慢性病盛行率的上升和老年人口的增加大大增加了醫療應用中生物聚合物的市場需求。此外，創新和研究至關重要，重點是開發滿足特定醫療需求的客製化生物聚合物，並最佳化性能以適應臨床應用。探索永續生產方法並與醫療保健實體建立牢固的關係也有助於推動這一令人興奮的領域的發展。監管支持和生物聚合物研發投資的增加進一步支持了市場，旨在增強生物相容性、生物功能性、機械性能、分解率和免疫原性。

全球醫療應用生物聚合物市場研究涵蓋的關鍵區域包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於醫療生物聚合物消費的成長和創新、強大的醫療基礎設施、先進的醫療設施以及對永續材料的高度重視等因素，北美在醫療應用生物聚合物市場上處於領先地位。然而，在多樣化的消費者需求和龐大的農業足跡的推動下，預計亞太地區的市場在預測期內將以最快的速度成長。

目錄

第 1 章：全球醫療應用生物聚合物市場執行摘要

  • 全球醫療應用生物聚合物市場規模及預測（2022-2032）
  • 區域概要
  • 分部摘要
    • 按類型
    • 按來源
    • 按申請
  • 主要趨勢
  • 經濟衰退的影響
  • 分析師推薦與結論

第 2 章：全球醫療應用生物聚合物市場定義與研究假設

  • 研究目的
  • 市場定義
  • 研究假設
    • 包容與排除
    • 限制
    • 供給側分析
      • 可用性
      • 基礎設施
      • 監管環境
      • 市場競爭
      • 經濟可行性（消費者的角度）
    • 需求面分析
      • 監理框架
      • 技術進步
      • 環境考慮
      • 消費者意識和接受度
  • 估算方法
  • 研究涵蓋的年份
  • 貨幣兌換率

第 3 章：全球醫療應用生物聚合物市場動態

  • 市場促進因素
    • 生物相容性材料需求激增
    • 生物聚合物的技術進步
    • 慢性病盛行率上升
  • 市場挑戰
    • 研發成本高
    • 嚴格的監管環境
    • 來自合成聚合物的競爭
  • 市場機會
    • 生產效率和新型生物聚合物的進步
    • 永續生產方法

第 4 章：全球醫療應用生物聚合物市場產業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭競爭
    • 波特五力模型的未來方法
    • 波特的 5 力影響分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會的
    • 技術性
    • 環境的
    • 合法的
  • 頂級投資機會
  • 最佳制勝策略
  • 顛覆性趨勢
  • 產業專家視角
  • 分析師推薦與結論

第 5 章：2022-2032 年全球醫療應用生物聚合物市場規模及類型預測

  • 細分儀表板
  • 全球醫療應用生物聚合物市場：類型收入趨勢分析，2022 年和 2032 年
    • 生物基聚乙烯
    • 可生物分解澱粉混合物
    • 生物PC
    • 生物PET
    • 生物聚氨酯
    • 纖維素衍生物
    • PHA
    • 再生纖維素

第 6 章：2022-2032 年全球醫療應用生物聚合物市場規模及來源預測

  • 細分儀表板
  • 全球醫療應用生物聚合物市場：2022 年和 2032 年來源收入趨勢分析
    • 自然的
    • 合成的

第 7 章：2022-2032 年全球醫療應用生物聚合物市場規模及應用預測

  • 細分儀表板
  • 全球醫療應用生物聚合物市場：2022 年和 2032 年應用收入趨勢分析
    • 生物可吸收支架
    • 牙科
    • 藥物輸送系統
    • 治療產品
    • 外科植入裝置
    • 治療影像
    • 傷口閉合

第 8 章：2022-2032 年全球醫療應用生物聚合物市場規模及按地區預測

  • 北美醫療應用生物聚合物市場
    • 美國醫療應用生物聚合物市場
      • 2022-2032 年型別細分規模與預測
      • 2022-2032 年來源細分規模與預測
      • 2022-2032 年應用細分規模與預測
    • 加拿大醫療應用生物聚合物市場
  • 歐洲醫療應用生物聚合物市場
    • 英國醫療應用市場生物聚合物
    • 德國醫療應用市場生物聚合物
    • 法國醫療應用生物聚合物市場
    • 西班牙醫療應用生物聚合物市場
    • 義大利醫療應用生物聚合物市場
    • 歐洲其他地區醫療應用生物聚合物市場
  • 亞太地區醫療應用生物聚合物市場
    • 中國醫療應用生物聚合物市場
    • 印度醫療應用生物聚合物市場
    • 日本醫療應用生物聚合物市場
    • 澳洲醫療應用生物聚合物市場
    • 韓國醫療應用市場生物聚合物
    • 亞太地區其他地區醫療應用生物聚合物市場
  • 拉丁美洲醫療應用市場的生物聚合物
    • 巴西醫療應用市場生物聚合物
    • 墨西哥醫療應用市場生物聚合物
    • 拉丁美洲其他地區醫療應用生物聚合物市場
  • 中東和非洲醫療應用市場的生物聚合物
    • 沙烏地阿拉伯醫療應用市場的生物聚合物
    • 南非醫療應用生物聚合物市場
    • 中東和非洲其他地區的醫療應用生物聚合物市場

第 9 章：競爭情報

  • 重點企業SWOT分析
  • 頂級市場策略
  • 公司簡介
    • BASF SE
      • 關鍵訊息
      • 概述
      • 財務（視數據可用性而定）
      • 產品概要
      • 市場策略
    • Biesterfeld AG
    • BioPolymer GmbH & Co. KG
    • Blafar Ltd.
    • Corbion NV
    • Danimer Scientific, Inc.
    • DuPont de Nemours, Inc.
    • Eastman Chemical Company
    • Evonik Industries AG
    • Geistlich Pharma AG
    • GELITA AG
    • Green Dot Bioplastics Inc.
    • HTL
    • HyMedPoly
    • Invibio Ltd. by Victrex PLC

第 10 章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場預測
    • 驗證
    • 出版
  • 研究屬性
簡介目錄

Global Biopolymers for Medical Applications Market is valued at approximately USD 2.43 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 23.24% over the forecast period 2024-2032. Biopolymers are natural or biologically synthesized polymers, essential in the creation of cutting-edge medical tools and devices, such as biodegradable stents, drug delivery systems, and sutures, admired for their compatibility with the human body, natural decomposition, and reduced toxicity. Their diverse applications span regenerative medicine, pharmaceuticals, and surgical procedures, driven by the surging need for biocompatible materials and groundbreaking technological progression. The market teems with opportunities, promising advances in production efficiency and novel biopolymers featuring smart functional properties like stimuli-responsiveness. However, the industry faces constraints including the steep costs of research and development, stringent regulatory landscapes, and competition from synthetic polymers.

The rising prevalence of chronic diseases and a growing elderly population significantly contribute to the market demand for biopolymers in medical applications. Additionally, innovation and research are pivotal, focusing on developing tailored biopolymers for specific medical needs and optimizing performance to align with clinical applications. Exploring sustainable production methods and forging strong relationships with healthcare entities are also instrumental in advancing this exciting field. The market is further bolstered by regulatory support and increasing investments in biopolymer R&D, aimed at enhancing biocompatibility, biofunctionality, mechanical properties, degradation rates, and immunogenicity.

Key regions considered for the global Biopolymers for Medical Applications market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. The North America leads the Biopolymers for Medical Applications market owing to factors such as rise in consumption and innovation in biopolymers for medical, robust medical infrastructure, advanced healthcare facilities, and a strong focus on sustainable materials. Whereas, the market in Asia Pacific is anticipated to grow at the fastest rate over the forecast period fueled by diverse consumer needs and significant agricultural footprints.

Major market players included in this report are:

  • BASF SE
  • Biesterfeld AG
  • BioPolymer GmbH & Co. KG
  • Blafar Ltd.
  • Corbion NV
  • Danimer Scientific, Inc.
  • DuPont de Nemours, Inc.
  • Eastman Chemical Company
  • Evonik Industries AG
  • Geistlich Pharma AG
  • GELITA AG
  • Green Dot Bioplastics Inc.
  • HTL
  • HyMedPoly
  • Invibio Ltd. by Victrex PLC

The detailed segments and sub-segment of the market are explained below:

By Type:

  • Bio-Based Polyethylene
  • Bio-Degradable Starch Blends
  • Bio-PC
  • Bio-PET
  • Bio-PUR
  • Cellulose Derivatives
  • PHA
  • Regenerated Cellulose

By Source:

  • Natural
  • Synthetic

By Application:

  • Bioresorbable Scaffolds
  • Dentistry
  • Drug Delivery Systems
  • Healing Products
  • Surgical Implant Devices
  • Therapeutic Imaging
  • Wound Closure

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Biopolymers for Medical Applications Market Executive Summary

  • 1.1. Global Biopolymers for Medical Applications Market Size & Forecast (2022- 2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Type
    • 1.3.2. By Source
    • 1.3.3. By Application
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Biopolymers for Medical Applications Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Biopolymers for Medical Applications Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Surging demand for biocompatible materials
    • 3.1.2. Technological advancements in biopolymers
    • 3.1.3. Rising prevalence of chronic diseases
  • 3.2. Market Challenges
    • 3.2.1. High costs of research and development
    • 3.2.2. Stringent regulatory landscapes
    • 3.2.3. Competition from synthetic polymers
  • 3.3. Market Opportunities
    • 3.3.1. Advances in production efficiency and novel biopolymers
    • 3.3.2. Sustainable production methods

Chapter 4. Global Biopolymers for Medical Applications Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Biopolymers for Medical Applications Market Size & Forecasts by Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Biopolymers for Medical Applications Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Bio-Based Polyethylene
    • 5.2.2. Bio-Degradable Starch Blends
    • 5.2.3. Bio-PC
    • 5.2.4. Bio-PET
    • 5.2.5. Bio-PUR
    • 5.2.6. Cellulose Derivatives
    • 5.2.7. PHA
    • 5.2.8. Regenerated Cellulose

Chapter 6. Global Biopolymers for Medical Applications Market Size & Forecasts by Source 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Biopolymers for Medical Applications Market: Source Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Natural
    • 6.2.2. Synthetic

Chapter 7. Global Biopolymers for Medical Applications Market Size & Forecasts by Application 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Biopolymers for Medical Applications Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 7.2.1. Bioresorbable Scaffolds
    • 7.2.2. Dentistry
    • 7.2.3. Drug Delivery Systems
    • 7.2.4. Healing Products
    • 7.2.5. Surgical Implant Devices
    • 7.2.6. Therapeutic Imaging
    • 7.2.7. Wound Closure

Chapter 8. Global Biopolymers for Medical Applications Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Biopolymers for Medical Applications Market
    • 8.1.1. U.S. Biopolymers for Medical Applications Market
      • 8.1.1.1. Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Source breakdown size & forecasts, 2022-2032
      • 8.1.1.3. Application breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Biopolymers for Medical Applications Market
  • 8.2. Europe Biopolymers for Medical Applications Market
    • 8.2.1. U.K. Biopolymers for Medical Applications Market
    • 8.2.2. Germany Biopolymers for Medical Applications Market
    • 8.2.3. France Biopolymers for Medical Applications Market
    • 8.2.4. Spain Biopolymers for Medical Applications Market
    • 8.2.5. Italy Biopolymers for Medical Applications Market
    • 8.2.6. Rest of Europe Biopolymers for Medical Applications Market
  • 8.3. Asia-Pacific Biopolymers for Medical Applications Market
    • 8.3.1. China Biopolymers for Medical Applications Market
    • 8.3.2. India Biopolymers for Medical Applications Market
    • 8.3.3. Japan Biopolymers for Medical Applications Market
    • 8.3.4. Australia Biopolymers for Medical Applications Market
    • 8.3.5. South Korea Biopolymers for Medical Applications Market
    • 8.3.6. Rest of Asia Pacific Biopolymers for Medical Applications Market
  • 8.4. Latin America Biopolymers for Medical Applications Market
    • 8.4.1. Brazil Biopolymers for Medical Applications Market
    • 8.4.2. Mexico Biopolymers for Medical Applications Market
    • 8.4.3. Rest of Latin America Biopolymers for Medical Applications Market
  • 8.5. Middle East & Africa Biopolymers for Medical Applications Market
    • 8.5.1. Saudi Arabia Biopolymers for Medical Applications Market
    • 8.5.2. South Africa Biopolymers for Medical Applications Market
    • 8.5.3. Rest of Middle East & Africa Biopolymers for Medical Applications Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. BASF SE
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Biesterfeld AG
    • 9.3.3. BioPolymer GmbH & Co. KG
    • 9.3.4. Blafar Ltd.
    • 9.3.5. Corbion NV
    • 9.3.6. Danimer Scientific, Inc.
    • 9.3.7. DuPont de Nemours, Inc.
    • 9.3.8. Eastman Chemical Company
    • 9.3.9. Evonik Industries AG
    • 9.3.10. Geistlich Pharma AG
    • 9.3.11. GELITA AG
    • 9.3.12. Green Dot Bioplastics Inc.
    • 9.3.13. HTL
    • 9.3.14. HyMedPoly
    • 9.3.15. Invibio Ltd. by Victrex PLC

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes